Editors Choice Article | Genus Moquiniastrum (Asteraceae): Overview of Chemical and Bioactivity Studies


Journal Name: Current Bioactive Compounds

Author(s): Victoria de Moraes Goncalves, Angelita Da Silveira Moreira*, Patricia Diaz de Oliveira.



The genus Moquiniastrum belongs to the Asteraceae family and is widely and exclusively dispersed throughout South America. Its species adapt easily to different cultivation conditions, and present a varied chemical composition with a great performance in pharmacological and pharmacognosy studies, mainly for sesquiterpene lactones. Moquiniastrum polymorphum is a species distinguished in the genus, presenting socioeconomic potential in several sectors, besides great application in folk medicine to treat respiratory diseases. The bioactive properties highlighted in the research are antioxidant, allelopathic, anti-inflammatory, insecticidal, antiviral and antimicrobial activity, and toxicity against different cancer lines, among others. To date, from 21 species belonging to the genus Moquiniastrum 11 species have been studied for their chemical composition, and only five species have been studied for their biological or toxicological activity. Different parts of the plants have been analysed, such as flowers, leaves and bark of the trunk and roots, and extracts obtained by different extraction methods and solvents. The genus has in its chemical composition classes of molecules such as sesquiterpene lactones, sesquiterpenes, diterpenes, triterpenes, flavonoids, coumarins, caffeic acid derivatives, acetylene and non-protein amino acids. Isolation studies of the chemical constituents of the species are promising considering that they are safe to use since they do not cause changes in DNA and can be used even during the gestational period. To read out more, please visit: http://www.eurekaselect.com/162417/article

Call for Papers | Current Medicinal Chemistry


Special Thematic Issues | Forthcoming Issues

Journal: Current Medicinal Chemistry


Medicinal Plants and Mushrooms as Unfailing Source of Pharmacological Active Molecules for the Treatment and Supportive Therapy in Chronic Diseases and Conditions


This thematic issue will cover the effects of medicinal plants, mushrooms and isolated compounds from them on chronic diseases and conditions. The role of bioactive compounds from mushrooms in skin disorders will be described within this thematic issue, as well as the effects of plant extracts and isolated compounds in the treatment and prevention of chronic skin conditions. The inhibitory effects of medicinal plants and compounds on enzymes linked with chronic diseases therapy will be presented. Therapeutic potential of Lamiaceae plants in cardiovascular diseases will be covered, as well as plant products as antidiabetic agents. Anticancer activity of sesquiterpene lactones – compounds isolated from plants will be reviewed. Furthermore, medicinal plants and mushrooms as an alternative therapy for the treatment of chronic sinusitis and tonsillitis will be presented by the authors, as well as beneficial effects of fruits consumption in prevention and management of type 2 diabetes. For more details please visit: https://benthamscience.com/journal-files/special-issue-details/CMC-SII20181008-01.pdf


Guest Editor(s): Dejan Stojkovic, Milos Nikolic, Marina Sokovic
Tentative Publication Date: January, 2020


To submit your paper, email at: hermain@benthamscience.net and CC: faizan@benthamscience.net



%d bloggers like this: